Kirby McInerney LLP Investigates Shareholder Claims
Recent developments have prompted Kirby McInerney LLP to launch an investigation concerning potential shareholder claims against ADMA Biologics, Inc. (NASDAQ: ADMA). This law firm specializes in addressing legal matters specifically related to securities laws and ensuring shareholder rights are protected.
Concerns Regarding ADMA Biologics
The primary focus of this investigation is whether ADMA Biologics, its Board of Directors, and other officers have failed in their duty to uphold federal securities regulations. Upholding federal laws is critical for maintaining trust with investors, and any violation could lead to significant repercussions for the company and its officers.
Impact of Accounting Firm Resignation
On a notable occasion, ADMA Biologics disclosed that their independent auditor, CohnReznick LLP, had resigned. This announcement triggered a substantial decline in the company's stock price, dropping about 16% in a single day. Such dramatic price shifts can create an atmosphere of uncertainty among current and potential investors alike.
The Role of Kirby McInerney LLP
Kirby McInerney LLP is dedicated to serving the interests of shareholders and ensuring their rights are safeguarded through comprehensive legal analysis and action. If you have invested in ADMA Biologics and have relevant information regarding this situation, contacting Kirby McInerney LLP could provide you with clarity and guidance on your potential claims.
Your Rights as a Shareholder
It’s essential for shareholders to stay informed about the performance and governance of the companies they invest in. If you have acquired ADMA Biologics securities and seek to understand your position, reaching out to Kirby McInerney LLP is an important step. The firm encourages all shareholders who have information related to this investigation to come forward.
Background on ADMA Biologics
ADMA Biologics is focused on developing and commercializing products for the treatment of infectious diseases. As they operate in such a sensitive field, maintaining stakeholder trust through regulatory compliance and ethical practices is vital. The firm's previous successes demonstrate its ability to recover significant funds for shareholders who have suffered losses due to non-compliance with federal regulations.
Contact Kirby McInerney LLP for More Information
If you have any questions, or if you’re interested in learning more about the investigation, you are encouraged to reach out directly to Thomas W. Elrod at Kirby McInerney LLP. The firm provides various avenues for communication, including emails and contact forms, to effectively discuss your legal interests.
Commitment to Shareholder Justice
As a New York-based plaintiffs' law firm, Kirby McInerney LLP remains committed to fighting for the rights of investors in securities litigation cases. Their diligent work has led to the recovery of billions of dollars for those affected by illegal corporate practices. Shareholders deserve a robust legal ally when disputes arise, ensuring their interests are effectively represented.
Frequently Asked Questions
What is the current status of the investigation against ADMA Biologics?
The investigation is currently ongoing, with Kirby McInerney LLP gathering information regarding potential violations of federal securities laws.
How did ADMA Biologics' stock price react to recent news?
The announcement of the auditor's resignation caused a significant drop in ADMA Biologics' stock price, illustrating immediate market reactions to corporate governance issues.
How can shareholders report information related to ADMA Biologics?
Shareholders can contact Kirby McInerney LLP directly through email or their provided contact form, ensuring a secure means of sharing information.
What type of legal matters does Kirby McInerney LLP handle?
Kirby McInerney LLP specializes in securities, antitrust, whistleblower, and consumer litigation, focusing on protecting shareholders’ rights.
What should I do if I purchased ADMA Biologics shares?
If you have acquired shares and wish to understand your rights or any claims you may have, reach out to Kirby McInerney LLP for guidance.
